General Information of the Compound
Compound ID
CP0072382
Compound Name
CHEBI:35591
    Show/Hide
Synonyms
16alpha-carbonitrile, pregnenolone
pregnenolone-16alpha-carbonitrile
    Show/Hide
Structure
Formula
C22H31NO2
Molecular Weight
341.495
Canonical SMILES
CC(=O)[C@H]1[C@@H](C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C#N
    Show/Hide
InChI
InChI=1S/C22H31NO2/c1-13(24)20-14(12-23)10-19-17-5-4-15-11-16(25)6-8-21(15,2)18(17)7-9-22(19,20)3/h4,14,16-20,25H,5-11H2,1-3H3/t14-,16-,17+,18-,19-,20-,21-,22-/m0/s1
    Show/Hide
InChIKey
VSBHRRMYCDQLJF-ZDNYCOCVSA-N
CAS
1434-54-4
25875-43-8
107316-48-3
Physicochemical Property
logP
4.26498
Rotatable Bonds
1
Heavy Atom Count
25
Polar Areas
61.09
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 15032
SID: 14924923
ChEMBL ID
CHEMBL1400945
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000015 SW480 Homo sapiens (Human)  1
1
Potency ~ 25929 nM
   TI
   LI
   LO
   TS
Protein ID: PT00967, Glucocorticoid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000162 HeLa S3 Homo sapiens (Human)  2
1
IC50 = 13957 nM
   TI
   LI
   LO
   TS
2
Ki = 6344 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( pregnenolone-16alpha-carbonitrile )
Drug Name pregnenolone-16alpha-carbonitrile
Target(s)
Pregnane X receptor (NR1I2)
Agonist